Correlation of histone methyl marks with circulating nucleosomes in blood plasma of cancer patients

被引:11
|
作者
Gezer, Ugur [1 ]
Mert, Ufuk [1 ]
Ozgur, Emre [1 ]
Yoruker, Ebru E. [1 ]
Holdenrieder, Stefan [2 ]
Dalay, Nejat [1 ]
机构
[1] Istanbul Univ, Dept Basic Oncol, Inst Oncol, TR-34390 Istanbul, Turkey
[2] Univ Bonn, Inst Clin Chem & Pharmacol, D-53127 Bonn, Germany
关键词
cancer; blood plasma; circulating nucleosomes; histone methylation; CELL LUNG-CANCER; NUCLEIC-ACIDS; HEALTHY; DNA; CHEMOTHERAPY;
D O I
10.3892/ol.2012.600
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Circulating DNA is present in plasma/serum, mainly complexed with histones as nucleosomes. The detection of circulating nucleosomes (cNUCs) in the peripheral blood may be a diagnostic modality for cancer-associated changes of modified histone tails in blood circulation. In the present study, we investigated the correlation between the trimethylation of H3 lysine 9 (H3K9me3) and H4 lysine 20 (H4K20me3), which are hallmarks of pericentric heterochromatin, and cNUCs in healthy subjects and patients with colorectal cancer (CRC) and multiple myeloma (MM). The plasma concentration of cNUCs was measured using the Cell-Death Detection ELISA kit. Histone methylation marks were detected using chromatin immunoprecipitation (ChIP), followed by quantitative PCR with pericentric satellite 2 as the target sequence. The results showed a high variation in the concentrations of cNUCs, with healthy subjects exhibiting the lowest levels (median 0.194), the CRC patients intermediate (median 0.25) and the MM patients the highest levels (median 0.648). However, the differences between the groups did not reach statistical significance (p>0.05). Analysis using the Pearson's correlation test revealed a significant positive correlation between the concentration of cNUCs and H3K9me3 and H4K20me3 in the whole study group (N=57, p<0.001 for both histone marks). A study of the correlation between cNUCs and histone marks in the individual study groups demonstrated the correlation between cNUCs and H3K9me3 in CRC patients to be weak (p=0.046), indicating that circulating H3K9me3 may be modified in CRC patients. The histone marks were normalized using the values of cNUCs. In agreement with the weak correlation between cNUCs and H3K9me3 in CRC patients, H3K9me3 levels (median 0.047) were lowest in this group compared with the other two groups (0.06 in healthy subjects, 0.2 in MM patients, p = not significant). For H4K20me3, the median values were 0.022 in healthy subjects, 0.052 in CRC patients and 0.056 in MM patients. In conclusion, our findings indicate a marked correlation between cNUCs and histone methyl marks.
引用
收藏
页码:1095 / 1098
页数:4
相关论文
共 50 条
  • [21] Circulating RNA in Blood Plasma as a Diagnostic Marker of Breast Cancer
    Turchaninova, M. A.
    Mesheryakov, A. A.
    Rakhmankulova, Z. P.
    Rebrikov, D. V.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2011, 37 (03) : 351 - 355
  • [22] Circulating RNA in blood plasma as a diagnostic marker of breast cancer
    M. A. Turchaninova
    A. A. Mesheryakov
    Z. P. Rakhmankulova
    D. V. Rebrikov
    Russian Journal of Bioorganic Chemistry, 2011, 37 : 351 - 355
  • [23] Correlation between 5-fluorouracil plasma and whole blood concentration in cancer patients
    Radovanovic, Mirjana
    Schneider, Jennifer J.
    Martin, Jennifer H.
    Johnstone, Janice M.
    Galettis, Peter
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 19 - 20
  • [24] Quantitation of circulating tumor cells in peripheral blood of breast cancer patients: correlation with stage and progression.
    Kahn, HJ
    Presta, A
    Yang, LY
    Blondal, J
    Trudeau, M
    Lickley, L
    Holloway, C
    McCready, D
    Maclean, D
    Marks, A
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 258 - 258
  • [25] Correlation between blood markers of hemostasis and circulating tumor cells (CTCs) in early breast cancer patients
    Mego, M.
    Karaba, M.
    Minarik, G.
    Benca, J.
    Sedlackova, T.
    Tothova, L.
    Vlkova, B.
    Cierna, Z.
    Janega, P.
    Manasova, D.
    Luha, J.
    Gronesova, P.
    Pechan, J.
    Fridrichova, I.
    Celec, P.
    Reuben, J. M.
    Cristofanilli, M.
    Mardiak, J.
    CANCER RESEARCH, 2013, 73
  • [26] Circulating nucleosomes predict the response to chemotherapy in patients with advanced non-small cell lung cancer
    Holdenrieder, S
    Stieber, P
    von Pawel, J
    Raith, H
    Nagel, D
    Feldmann, K
    Seidel, D
    CLINICAL CANCER RESEARCH, 2004, 10 (18) : 5981 - 5987
  • [27] Quantification of circulating DNA in the plasma and serum of cancer patients
    Taback, B
    O'Day, SJ
    Hoon, DSB
    CIRCULATING NUCLEIC ACIDS IN PLASMA/SERUM III AND SERUM PROTEOMICS, 2004, 1022 : 17 - 24
  • [28] Assessment of Circulating microRNAs in Plasma of Lung Cancer Patients
    Fortunato, Orazio
    Boeri, Mattia
    Verri, Carla
    Conte, Davide
    Mensah, Mavis
    Suatoni, Paola
    Pastorino, Ugo
    Sozzi, Gabriella
    MOLECULES, 2014, 19 (03): : 3038 - 3054
  • [29] Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients
    Nikolaus Kohles
    Dorothea Nagel
    Dietrich Jüngst
    Jürgen Durner
    Petra Stieber
    Stefan Holdenrieder
    BMC Cancer, 11
  • [30] Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients
    Kohles, Nikolaus
    Nagel, Dorothea
    Juengst, Dietrich
    Durner, Juergen
    Stieber, Petra
    Holdenrieder, Stefan
    BMC CANCER, 2011, 11